“Frequent exacerbator” is a phenotype of poor prognosis in Japanese patients with chronic obstructive pulmonary disease

References

• GOLD (Global initiative for chronic Obstructive Lung Disease)Global Strategy for Diagnosis, Management, and Prevention of COPDBethesda (MD)GOLD2015
   Google Scholar
• SinganayagamASchembriSChalmersJDPredictors of mortality in hospitalized adults with acute exacerbation of chronic obstructive pulmonary diseaseAnn Am Thorac Soc2013102818923607835
   PubMedGoogle Scholar
• Bustamante-FermoselADe Miguel-YanesJMDuffort-FalcóMMuñozJMortality-related factors after hospitalization for acute exacerbation of chronic obstructive pulmonary disease: the burden of clinical featuresAm J Emerg Med200725551552217543654
   PubMed Web of Science ®Google Scholar
• GroenewegenKHScholsAMWoutersEFMortality and mortality-related factors after hospitalization for acute exacerbation of COPDChest2003124245946712907529
   PubMed Web of Science ®Google Scholar
• SeemungalTAHurstJRWedzichaJAExacerbation rate, health status and mortality in COPD – a review of potential interventionsInt J Chron Obstruct Pulmon Dis2009420322319554195
   PubMedGoogle Scholar
• SpencerSCalverleyPMBurgePSJonesPWImpact of preventing exacerbations on deterioration of health status in COPDEur Respir J200423569870215176682
   PubMed Web of Science ®Google Scholar
• SeemungalTADonaldsonGCPaulEABestallJCJeffriesDJWedzichaJAEffect of exacerbation on quality of life in patients with chronic obstructive pulmonary diseaseAm J Respir Crit Care Med19981575 Pt 1141814229603117
   PubMed Web of Science ®Google Scholar
• CelliBRThomasNEAndersonJAEffect of pharmacotherapy on rate of decline of lung function in chronic obstructive pulmonary disease: results from the TORCH studyAm J Respir Crit Care Med2008178433233818511702
   PubMed Web of Science ®Google Scholar
• MakrisDMoschandreasJDamianakiAExacerbations and lung function decline in COPD: new insights in current and ex-smokersRespir Med200710161305131217112715
   PubMed Web of Science ®Google Scholar
• DonaldsonGCSeemungalTABhowmikAWedzichaJARelationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary diseaseThorax2002571084785212324669
   PubMed Web of Science ®Google Scholar
• Soler-CataluñaJJMartínez-GarcíaMARomán SánchezPSalcedoENavarroMOchandoRSevere acute exacerbations and mortality in patients with chronic obstructive pulmonary diseaseThorax2005601192593116055622
   PubMed Web of Science ®Google Scholar
• HurstJRVestboJAnzuetoASusceptibility to exacerbation in chronic obstructive pulmonary diseaseN Engl J Med2010363121128113820843247
   PubMed Web of Science ®Google Scholar
• SuzukiMMakitaHItoYMNagaiKKonnoSNishimuraMClinical features and determinants of COPD exacerbation in the Hokkaido COPD cohort studyEur Respir J20144351289129724232696
   PubMed Web of Science ®Google Scholar
• FukuchiYFernandezLKuoHPEfficacy of tiotropium in COPD patients from Asia: a subgroup analysis from the UPLIFT trialRespirology201116582583521539680
   PubMed Web of Science ®Google Scholar
• TatsumiKKasaharaYKurosuKTanabeNTakiguchiYKuriyamaTClinical phenotypes of COPD: results of a Japanese epidemiological surveyRespirology20049333133615363004
   PubMed Web of Science ®Google Scholar
• BeehKMGlaabTStowasserSCharacterisation of exacerbation risk and exacerbator phenotypes in the POET-COPD trialRespir Res20131411624168767
   PubMed Web of Science ®Google Scholar
• BestallJCPaulEAGarrodRGarnhamRJonesPWWedzichaJAUsefulness of the Medical Research Council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary diseaseThorax199954758158610377201
   PubMed Web of Science ®Google Scholar
• TsudaTSuematsuRKamoharaKDevelopment of the Japanese version of the COPD Assessment TestRespir Investig20125023439
   PubMedGoogle Scholar
• JonesPWHardingGBerryPWiklundIChenWHKline LeidyNDevelopment and first validation of the COPD Assessment TestEur Respir J200934364865419720809
   PubMed Web of Science ®Google Scholar
• KusanoMShimoyamaYSugimotoSDevelopment and evaluation of FSSG: frequency scale for the symptoms of GERDJ Gastroenterol200439988889115565409
   PubMed Web of Science ®Google Scholar
• ItoKKawayamaTShojiYDepression, but not sleep disorder, is an independent factor affecting exacerbations and hospitalization in patients with chronic obstructive pulmonary diseaseRespirology201217694094922564039
   PubMed Web of Science ®Google Scholar
• SuetomoMKawayamaTKinoshitaTCOPD assessment tests scores are associated with exacerbations in Japanese patients with chronic obstructive pulmonary diseaseRespir Investig2014525288295
   Google Scholar
• TashkinDPCelliBSennSA 4-year trial of tiotropium in chronic obstructive pulmonary diseaseN Engl J Med2008359151543155418836213
   PubMed Web of Science ®Google Scholar
• Global Initiative for AsthmaGlobal Strategy for Asthma Management and PreventionBethesda (MD)GINA2015
   Google Scholar
• Soler–CataluñaJJCosíoBIzquierdoJLConsensus document on the overlap phenotype COPD-asthma in COPDArch Bronconeumol201248933133722341911
   PubMed Web of Science ®Google Scholar
• DivoMCoteCde TorresJPComorbidities and risk of mortality in patients with chronic obstructive pulmonary diseaseAm J Respir Crit Care Med2012186215516122561964
   PubMed Web of Science ®Google Scholar
• CharlsonMEPompeiPAlesKLMacKenzieCRA new method of classifying prognostic comorbidity in longitudinal studies: development and validationJ Chronic Dis19874053733833558716
   PubMedGoogle Scholar
• Japan Diabetes SocietyEvidence-based practice guideline for the treatment of diabetes in Japan 20132014 Available from: http://www.jds.or.jp/modules/en/index.php?content_id=44Accessed December 23, 2015
   Google Scholar
• Rodriguez-RoisinRToward a consensus definition for COPD exacerbationsChest20001175 Suppl 2398S401S10843984
   PubMed Web of Science ®Google Scholar
• CalverleyPMAndersonJACelliBSalmeterol and fluticasone propionate and survival in chronic obstructive pulmonary diseaseN Engl J Med2007356877578917314337
   PubMed Web of Science ®Google Scholar
• KesslerRFallerMFourgautGMennecierBWeitzenblumEPredictive factors of hospitalization for acute exacerbation in a series of 64 patients with chronic obstructive pulmonary diseaseAm J Respir Crit Care Med199915911581649872834
   PubMed Web of Science ®Google Scholar
• McGarveyLLeeAJRobertsJGruffydd-JonesKMcKnightEHaughneyJCharacterisation of the frequent exacerbator phenotype in COPD patients in a large UK primary care populationRespir Med2015109222823725613107
   PubMed Web of Science ®Google Scholar
• BalcellsEAntóJMGeaJCharacteristics of patients admitted for the first time for COPD exacerbationRespir Med200910391293130219427776
   PubMed Web of Science ®Google Scholar
• DonaldsonGCMüllerovaHLocantoreNFactors associated with change in exacerbation frequency in COPDRespir Res2013147923899210
   PubMed Web of Science ®Google Scholar
• XuWColletJPShapiroSNegative impacts of unreported COPD exacerbations on health-related quality of life at 1 yearEur Respir J20103551022103019897555
   PubMed Web of Science ®Google Scholar
• LangsetmoLPlattRWErnstPBourbeauJUnderreporting exacerbation of chronic obstructive pulmonary disease in a longitudinal cohortAm J Respir Crit Care Med2008177439640118048806
   PubMed Web of Science ®Google Scholar
• WiseRAAnzuetoACottonDTiotropium Respimat inhaler and the risk of death in COPDN Engl J Med2013369161491150123992515
   PubMed Web of Science ®Google Scholar
• TanabeNMuroSHiraiTImpact of exacerbations on emphysema progression in chronic obstructive pulmonary diseaseAm J Respir Crit Care Med2011183121653165921471102
   PubMed Web of Science ®Google Scholar
• AtlantisEFaheyPCochraneBSmithSBidirectional associations between clinically relevant depression or anxiety and COPD: a systematic review and meta-analysisChest2013144376677723429910
   PubMed Web of Science ®Google Scholar
• MenezesAMMontes de OcaMPérez-PadillaRIncreased risk of exacerbation and hospitalization in subjects with an overlap phenotype: COPD-asthmaChest2014145229730424114498
   PubMed Web of Science ®Google Scholar
• FisherKAStefanMSDarlingCLessardDGoldbergRJImpact of COPD on the mortality and treatment of patients hospitalized with acute decompensated heart failure: the Worcester Heart Failure StudyChest2015147363764525188234
   PubMed Web of Science ®Google Scholar
• TeradaKMuroSSatoSImpact of gastrooesophageal reflux disease symptoms on COPD exacerbationThorax2008631195195518535116
   PubMed Web of Science ®Google Scholar
• Japanese Respiratory SocietyGuidelines for the diagnosis and treatment of COPD (chronic obstructive pulmonary disease)3rd edTokyoMedical Review Co2009 Japanese
   Google Scholar
• CrimCDransfieldMTBourbeauJPneumonia risk with inhaled fluticasone furoate and vilanterol compared with vilanterol alone in patients with COPDAnn Am Thorac Soc2015121273425490706
   PubMed Web of Science ®Google Scholar
• DiSantostefanoRLSampsonTLeHVHindsDDavisKJBakerlyNDRisk of pneumonia with inhaled corticosteroid versus long-acting bronchodilator regimens in chronic obstructive pulmonary disease: a new-user cohort studyPLoS One201495e9714924878543
   PubMed Web of Science ®Google Scholar
• KewKMSeniukovichAInhaled steroids and risk of pneumonia for chronic obstructive pulmonary diseaseCochrane Database Syst Rev20143CD01011524615270
   PubMed Web of Science ®Google Scholar